T cells and their products in diabetic kidney disease
Authors:
Open Access
- 26 January 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1084448
Abstract
Diabetic kidney disease (DKD) is the most common cause of end-stage renal disease and has gradually become a public health problem worldwide. DKD is increasingly recognized as a comprehensive inflammatory disease that is largely regulated by T cells. Given the pivotal role of T cells and T cells-producing cytokines in DKD, we summarized recent advances concerning T cells in the progression of type 2 diabetic nephropathy and provided a novel perspective of immune-related factors in diabetes. Specific emphasis is placed on the classification of T cells, process of T cell recruitment, function of T cells in the development of diabetic kidney damage, and potential treatments and therapeutic strategies involving T cells.Keywords
Funding Information
- National Natural Science Foundation of China
- Taishan Scholar Foundation of Shandong Province
This publication has 198 references indexed in Scilit:
- Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiationNature Immunology, 2013
- Role of T Cells in Type 2 Diabetic NephropathyExperimental Diabetes Research, 2011
- IL-21 and IL-6 Are Critical for Different Aspects of B Cell Immunity and Redundantly Induce Optimal Follicular Helper CD4 T Cell (Tfh) DifferentiationPLOS ONE, 2011
- Generation of pathogenic TH17 cells in the absence of TGF-β signallingNature, 2010
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsJournal of Experimental Medicine, 2010
- Normalization of obesity-associated insulin resistance through immunotherapyNature Medicine, 2009
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune DestructionImmunity, 2008
- T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-γ and IL-13 productionProceedings of the National Academy of Sciences, 2007
- Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetesImmunology, 2007
- NK Cells and Type 1 DiabetesJournal of Immunology Research, 2006